Get started
Author

Mattia Capulli

Observed names: CAPULLI, MATTIA, Capulli Mattia, Capulli, Mattia, M. Capulli, M. Capulli⁎
Observed institutions: University of L'Aquila, IPO Porto
ORCID: 0000-0003-0449-6720
Observed ORCID: 0000-0003-0449-6720
OpenAlex ID: A5024526919
Osteoblast and osteocyte: Games without frontiers
2014 · Mattia Capulli, Riccardo Paone, et al. · Archives of Biochemistry and Biophysics · 414
Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans
2011 · Anna Rufo, Andrea Del Fattore, et al. · Journal of Bone and Mineral Research · 145
PDF
Generation and culture of osteoclasts
2014 · Silvia Marino, John G Logan, et al. · BoneKEy Reports · 115
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis
2014 · Nadia Rucci, Mattia Capulli, et al. · Journal of Bone and Mineral Research · 107
PDF
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression
2014 · Patrizia Sanità, Mattia Capulli, et al. · BMC Cancer · 102
PDF
The glycosaminoglycan-binding domain of PRELP acts as a cell type–specific NF-κB inhibitor that impairs osteoclastogenesis
2009 · Nadia Rucci, Anna Rufo, et al. · The Journal of Cell Biology · 86
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
2010 · M. Salerno, E. Cenni, et al. · Current Cancer Drug Targets · 82
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry
2019 · Mattia Capulli, Dayana Hristova, et al. · British Journal of Cancer · 79
PDF
Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a “mechanoresponsive osteoblast gene signature”
2009 · Mattia Capulli, Anna Rufo, et al. · Journal of Cellular Biochemistry · 69
A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy Metabolism
2018 · Mattia Capulli, Marco Ponzetti, et al. · Journal of Bone and Mineral Research · 57
PDF
Non-conventional role of haemoglobin beta in breast malignancy
2017 · Marco Ponzetti, Mattia Capulli, et al. · British Journal of Cancer · 54
PDF
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk
2016 · Vimal Veeriah, Angelo Zanniti, et al. · Scientific Reports · 48
PDF
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
2019 · Silvia Marino, Daniëlle de Ridder, et al. · EBioMedicine · 45
PDF
Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
2009 · Dominique D Pierroz, Anna Rufo, et al. · PubMed · 44
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models
2013 · Imranul Alam, Amie K. Gray, et al. · Bone · 42
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development
2020 · Ella P Dennis, Sarah M Edwards, et al. · Journal of Bone and Mineral Research · 39
PDF
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis
2018 · Prabha Peramuhendige, Silvia Marino, et al. · Scientific Reports · 38
PDF
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs
2012 · Mattia Capulli, Adriano Angelucci, et al. · Journal of Bone and Mineral Research · 31
PDF
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development
2018 · Antonio Maurizi, Mattia Capulli, et al. · Bone · 30
Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2
2015 · Mattia Capulli, Antonio Maurizi, et al. · Molecular Therapy — Nucleic Acids · 29
PDF
The reference genome of the human diploid cell line RPE-1
2025 · Emilia Volpe, Alessio Colantoni, et al. · Nature Communications · 27
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis
2020 · Ryan T. Bishop, Silvia Marino, et al. · Cancer Letters · 27
PDF
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss
2013 · Nadia Rucci, Mattia Capulli, et al. · Journal of Bone and Mineral Research · 27
PDF
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation
2015 · Alfredo Cappariello, Riccardo Paone, et al. · Biomaterials · 26
PDF
The C-Terminal Domain of Chondroadherin: A New Regulator of Osteoclast Motility Counteracting Bone Loss
2014 · Mattia Capulli, Ole K Olstad, et al. · Journal of Bone and Mineral Research · 26
PDF
Works count: 115
Citation count: 2,009
H-index: 25
I10-index: 35
Year
Topic
Type